These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20019762)

  • 1. The effect of bevacizumab for anterior segment neovascularization after silicone oil removal in eyes with previous vitreoretinal surgery.
    Batman C; Ozdamar Y
    Eye (Lond); 2010 Jul; 24(7):1243-6. PubMed ID: 20019762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasilicone bevacizumab injection for iris neovascularization after vitrectomy for proliferative diabetic retinopathy.
    Salman AG
    Ophthalmic Res; 2013; 49(1):20-4. PubMed ID: 22986803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
    Lupinacci AP; Calzada JI; Rafieetery M; Charles S; Netland PA
    Adv Ther; 2009 Feb; 26(2):208-16. PubMed ID: 19234680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracameral bevacizumab for iris rubeosis.
    Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy.
    Oshima Y; Sakaguchi H; Gomi F; Tano Y
    Am J Ophthalmol; 2006 Jul; 142(1):155-8. PubMed ID: 16815267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
    Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
    J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S; Buchacra O; Milla E; Andreu D; Tellez J
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.
    Falavarjani KG; Modarres M; Nazari H
    Eye (Lond); 2010 Apr; 24(4):717-9. PubMed ID: 19407842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.
    Bopp S; Lucke K; Laqua H
    Ger J Ophthalmol; 1992; 1(6):375-81. PubMed ID: 1283355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
    Sothornwit N
    J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
    Amselem L; Montero J; Diaz-Llopis M; Pulido JS; Bakri SJ; Palomares P; Garcia-Delpech S
    Am J Ophthalmol; 2007 Jul; 144(1):122-4. PubMed ID: 17601432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.
    Jiang Y; Liang X; Li X; Tao Y; Wang K
    Acta Ophthalmol; 2009 Nov; 87(7):736-40. PubMed ID: 18803622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
    Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
    Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab as adjuvant for neovascular glaucoma.
    Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
    Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.